Home blood pressure monitors owned by participants in a large decentralised clinical trial in hypertension: the Treatment In Morning versus Evening (TIME) study
Various home blood pressure monitors (HBPMs) are available to the public for purchase but only some are validated against standardised protocols. This study aimed to assess whether HBPMs owned by participants taking part in a clinical trial were validated models. The TIME study is a decentralised ra...
Gespeichert in:
| Veröffentlicht in: | Journal of human hypertension 2022-01, Vol.36 (1), p.32-39 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 39 |
|---|---|
| container_issue | 1 |
| container_start_page | 32 |
| container_title | Journal of human hypertension |
| container_volume | 36 |
| creator | Anbarasan, Thineskrishna Rogers, Amy Rorie, David A. Kerr Grieve, J. W. MacDonald, Thomas M. Mackenzie, Isla S. |
| description | Various home blood pressure monitors (HBPMs) are available to the public for purchase but only some are validated against standardised protocols. This study aimed to assess whether HBPMs owned by participants taking part in a clinical trial were validated models. The TIME study is a decentralised randomised trial investigating the effect of antihypertensive medication dosing time on cardiovascular outcomes in adults with hypertension. No HBPMs were provided to participants in this trial but patients were asked to report if they already owned one. We identified the model of HBPM reported by participants, then cross-referenced this against lists of validated HBPMs produced by dabl Educational Trust and the British and Irish Hypertension Society (BIHS). Of 21,104 participants, 10,464 (49.6%) reported their model of HBPM. 7464 (71.3%) of these participants owned a monitor that could be identified from the participants’ entry. Of these, 6066 (81.3%) participants owned a monitor listed as validated by either dabl (
n
= 5903) or BIHS (
n
= 5491). Some were listed as validated by both. 1398 (18.7%) participants owned an identifiable HBPM that lacked clear evidence of validation. 6963 (93.3%) participants owned an upper arm HBPM and 501 (6.7%) owned a wrist HBPM. Validated HBPMs had a higher median online retail price of £45.00 compared to £20.00 for HBPMs lacking clear evidence of validation. A significant number of participants own HBPMs lacking evidence of validation. |
| doi_str_mv | 10.1038/s41371-021-00496-6 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8766290</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2490125398</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-ea78a9090a41389bedc28b66c930d319a611ddef16b65340615708d389247f4c3</originalsourceid><addsrcrecordid>eNp9ks2OFCEUhStG47SjL-DCkLgZF6X8FRQuTMykdTqZiZt2TSjqdjeTKiiBatNv46NKT4_jz8IFEHK_c-DCqaqXBL8lmLXvEidMkhrTMjBXohaPqgXhUtRNQ-XjaoFVg2tFOT6rnqV0i_Gx2D6tzhhrWiUbtah-XIURUDeE0KMpQkpzBDQG73KICYXvHnrUHdBkYnbWTcbnhJxHBg0mbgH1YMHnaAaXCmgH5501A8rRlblwu8MEMYNPLvj3KO8ArSOYPBYRWnl0E6J3fov2ENOc0HIPd9uL9epm-QalPPeH59WTjRkSvLhfz6uvn5bry6v6-svn1eXH69pyyXMNRrZGYYVNeZRWddBb2nZCWMVwz4gygpC-hw0RnWgYx4I0Erd9QSmXG27ZefXh5DvN3VjUp7b0FN1o4kEH4_TfFe92ehv2upVCUIWLwcW9QQzfZkhZjy5ZGAbjIcxJU64woQ1TbUFf_4Pehjn60p6mgpYmmJSiUPRE2RhSirB5uAzB-hgAfQqALgHQdwHQR9GrP9t4kPz68QKwE5BKyW8h_j77P7Y_AX7vvoo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2620903776</pqid></control><display><type>article</type><title>Home blood pressure monitors owned by participants in a large decentralised clinical trial in hypertension: the Treatment In Morning versus Evening (TIME) study</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Anbarasan, Thineskrishna ; Rogers, Amy ; Rorie, David A. ; Kerr Grieve, J. W. ; MacDonald, Thomas M. ; Mackenzie, Isla S.</creator><creatorcontrib>Anbarasan, Thineskrishna ; Rogers, Amy ; Rorie, David A. ; Kerr Grieve, J. W. ; MacDonald, Thomas M. ; Mackenzie, Isla S.</creatorcontrib><description>Various home blood pressure monitors (HBPMs) are available to the public for purchase but only some are validated against standardised protocols. This study aimed to assess whether HBPMs owned by participants taking part in a clinical trial were validated models. The TIME study is a decentralised randomised trial investigating the effect of antihypertensive medication dosing time on cardiovascular outcomes in adults with hypertension. No HBPMs were provided to participants in this trial but patients were asked to report if they already owned one. We identified the model of HBPM reported by participants, then cross-referenced this against lists of validated HBPMs produced by dabl Educational Trust and the British and Irish Hypertension Society (BIHS). Of 21,104 participants, 10,464 (49.6%) reported their model of HBPM. 7464 (71.3%) of these participants owned a monitor that could be identified from the participants’ entry. Of these, 6066 (81.3%) participants owned a monitor listed as validated by either dabl (
n
= 5903) or BIHS (
n
= 5491). Some were listed as validated by both. 1398 (18.7%) participants owned an identifiable HBPM that lacked clear evidence of validation. 6963 (93.3%) participants owned an upper arm HBPM and 501 (6.7%) owned a wrist HBPM. Validated HBPMs had a higher median online retail price of £45.00 compared to £20.00 for HBPMs lacking clear evidence of validation. A significant number of participants own HBPMs lacking evidence of validation.</description><identifier>ISSN: 0950-9240</identifier><identifier>EISSN: 1476-5527</identifier><identifier>DOI: 10.1038/s41371-021-00496-6</identifier><identifier>PMID: 33589759</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/308/2779/109 ; 692/699/75/243 ; 692/700/139 ; Adult ; Antihypertensives ; Blood Pressure ; Blood Pressure Monitoring, Ambulatory ; Blood Pressure Monitors ; Clinical trials ; Epidemiology ; Health Administration ; Humans ; Hypertension ; Hypertension - diagnosis ; Hypertension - drug therapy ; Medicine ; Medicine & Public Health ; Public Health ; Reproducibility of Results ; Sphygmomanometers ; Wrist</subject><ispartof>Journal of human hypertension, 2022-01, Vol.36 (1), p.32-39</ispartof><rights>The Author(s) 2021</rights><rights>2021. The Author(s).</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-ea78a9090a41389bedc28b66c930d319a611ddef16b65340615708d389247f4c3</citedby><cites>FETCH-LOGICAL-c474t-ea78a9090a41389bedc28b66c930d319a611ddef16b65340615708d389247f4c3</cites><orcidid>0000-0001-5207-7032</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41371-021-00496-6$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41371-021-00496-6$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,778,782,883,27911,27912,41475,42544,51306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33589759$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anbarasan, Thineskrishna</creatorcontrib><creatorcontrib>Rogers, Amy</creatorcontrib><creatorcontrib>Rorie, David A.</creatorcontrib><creatorcontrib>Kerr Grieve, J. W.</creatorcontrib><creatorcontrib>MacDonald, Thomas M.</creatorcontrib><creatorcontrib>Mackenzie, Isla S.</creatorcontrib><title>Home blood pressure monitors owned by participants in a large decentralised clinical trial in hypertension: the Treatment In Morning versus Evening (TIME) study</title><title>Journal of human hypertension</title><addtitle>J Hum Hypertens</addtitle><addtitle>J Hum Hypertens</addtitle><description>Various home blood pressure monitors (HBPMs) are available to the public for purchase but only some are validated against standardised protocols. This study aimed to assess whether HBPMs owned by participants taking part in a clinical trial were validated models. The TIME study is a decentralised randomised trial investigating the effect of antihypertensive medication dosing time on cardiovascular outcomes in adults with hypertension. No HBPMs were provided to participants in this trial but patients were asked to report if they already owned one. We identified the model of HBPM reported by participants, then cross-referenced this against lists of validated HBPMs produced by dabl Educational Trust and the British and Irish Hypertension Society (BIHS). Of 21,104 participants, 10,464 (49.6%) reported their model of HBPM. 7464 (71.3%) of these participants owned a monitor that could be identified from the participants’ entry. Of these, 6066 (81.3%) participants owned a monitor listed as validated by either dabl (
n
= 5903) or BIHS (
n
= 5491). Some were listed as validated by both. 1398 (18.7%) participants owned an identifiable HBPM that lacked clear evidence of validation. 6963 (93.3%) participants owned an upper arm HBPM and 501 (6.7%) owned a wrist HBPM. Validated HBPMs had a higher median online retail price of £45.00 compared to £20.00 for HBPMs lacking clear evidence of validation. A significant number of participants own HBPMs lacking evidence of validation.</description><subject>692/308/2779/109</subject><subject>692/699/75/243</subject><subject>692/700/139</subject><subject>Adult</subject><subject>Antihypertensives</subject><subject>Blood Pressure</subject><subject>Blood Pressure Monitoring, Ambulatory</subject><subject>Blood Pressure Monitors</subject><subject>Clinical trials</subject><subject>Epidemiology</subject><subject>Health Administration</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypertension - diagnosis</subject><subject>Hypertension - drug therapy</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Public Health</subject><subject>Reproducibility of Results</subject><subject>Sphygmomanometers</subject><subject>Wrist</subject><issn>0950-9240</issn><issn>1476-5527</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9ks2OFCEUhStG47SjL-DCkLgZF6X8FRQuTMykdTqZiZt2TSjqdjeTKiiBatNv46NKT4_jz8IFEHK_c-DCqaqXBL8lmLXvEidMkhrTMjBXohaPqgXhUtRNQ-XjaoFVg2tFOT6rnqV0i_Gx2D6tzhhrWiUbtah-XIURUDeE0KMpQkpzBDQG73KICYXvHnrUHdBkYnbWTcbnhJxHBg0mbgH1YMHnaAaXCmgH5501A8rRlblwu8MEMYNPLvj3KO8ArSOYPBYRWnl0E6J3fov2ENOc0HIPd9uL9epm-QalPPeH59WTjRkSvLhfz6uvn5bry6v6-svn1eXH69pyyXMNRrZGYYVNeZRWddBb2nZCWMVwz4gygpC-hw0RnWgYx4I0Erd9QSmXG27ZefXh5DvN3VjUp7b0FN1o4kEH4_TfFe92ehv2upVCUIWLwcW9QQzfZkhZjy5ZGAbjIcxJU64woQ1TbUFf_4Pehjn60p6mgpYmmJSiUPRE2RhSirB5uAzB-hgAfQqALgHQdwHQR9GrP9t4kPz68QKwE5BKyW8h_j77P7Y_AX7vvoo</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Anbarasan, Thineskrishna</creator><creator>Rogers, Amy</creator><creator>Rorie, David A.</creator><creator>Kerr Grieve, J. W.</creator><creator>MacDonald, Thomas M.</creator><creator>Mackenzie, Isla S.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5207-7032</orcidid></search><sort><creationdate>20220101</creationdate><title>Home blood pressure monitors owned by participants in a large decentralised clinical trial in hypertension: the Treatment In Morning versus Evening (TIME) study</title><author>Anbarasan, Thineskrishna ; Rogers, Amy ; Rorie, David A. ; Kerr Grieve, J. W. ; MacDonald, Thomas M. ; Mackenzie, Isla S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-ea78a9090a41389bedc28b66c930d319a611ddef16b65340615708d389247f4c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>692/308/2779/109</topic><topic>692/699/75/243</topic><topic>692/700/139</topic><topic>Adult</topic><topic>Antihypertensives</topic><topic>Blood Pressure</topic><topic>Blood Pressure Monitoring, Ambulatory</topic><topic>Blood Pressure Monitors</topic><topic>Clinical trials</topic><topic>Epidemiology</topic><topic>Health Administration</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypertension - diagnosis</topic><topic>Hypertension - drug therapy</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Public Health</topic><topic>Reproducibility of Results</topic><topic>Sphygmomanometers</topic><topic>Wrist</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anbarasan, Thineskrishna</creatorcontrib><creatorcontrib>Rogers, Amy</creatorcontrib><creatorcontrib>Rorie, David A.</creatorcontrib><creatorcontrib>Kerr Grieve, J. W.</creatorcontrib><creatorcontrib>MacDonald, Thomas M.</creatorcontrib><creatorcontrib>Mackenzie, Isla S.</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of human hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anbarasan, Thineskrishna</au><au>Rogers, Amy</au><au>Rorie, David A.</au><au>Kerr Grieve, J. W.</au><au>MacDonald, Thomas M.</au><au>Mackenzie, Isla S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Home blood pressure monitors owned by participants in a large decentralised clinical trial in hypertension: the Treatment In Morning versus Evening (TIME) study</atitle><jtitle>Journal of human hypertension</jtitle><stitle>J Hum Hypertens</stitle><addtitle>J Hum Hypertens</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>36</volume><issue>1</issue><spage>32</spage><epage>39</epage><pages>32-39</pages><issn>0950-9240</issn><eissn>1476-5527</eissn><abstract>Various home blood pressure monitors (HBPMs) are available to the public for purchase but only some are validated against standardised protocols. This study aimed to assess whether HBPMs owned by participants taking part in a clinical trial were validated models. The TIME study is a decentralised randomised trial investigating the effect of antihypertensive medication dosing time on cardiovascular outcomes in adults with hypertension. No HBPMs were provided to participants in this trial but patients were asked to report if they already owned one. We identified the model of HBPM reported by participants, then cross-referenced this against lists of validated HBPMs produced by dabl Educational Trust and the British and Irish Hypertension Society (BIHS). Of 21,104 participants, 10,464 (49.6%) reported their model of HBPM. 7464 (71.3%) of these participants owned a monitor that could be identified from the participants’ entry. Of these, 6066 (81.3%) participants owned a monitor listed as validated by either dabl (
n
= 5903) or BIHS (
n
= 5491). Some were listed as validated by both. 1398 (18.7%) participants owned an identifiable HBPM that lacked clear evidence of validation. 6963 (93.3%) participants owned an upper arm HBPM and 501 (6.7%) owned a wrist HBPM. Validated HBPMs had a higher median online retail price of £45.00 compared to £20.00 for HBPMs lacking clear evidence of validation. A significant number of participants own HBPMs lacking evidence of validation.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>33589759</pmid><doi>10.1038/s41371-021-00496-6</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-5207-7032</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0950-9240 |
| ispartof | Journal of human hypertension, 2022-01, Vol.36 (1), p.32-39 |
| issn | 0950-9240 1476-5527 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8766290 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | 692/308/2779/109 692/699/75/243 692/700/139 Adult Antihypertensives Blood Pressure Blood Pressure Monitoring, Ambulatory Blood Pressure Monitors Clinical trials Epidemiology Health Administration Humans Hypertension Hypertension - diagnosis Hypertension - drug therapy Medicine Medicine & Public Health Public Health Reproducibility of Results Sphygmomanometers Wrist |
| title | Home blood pressure monitors owned by participants in a large decentralised clinical trial in hypertension: the Treatment In Morning versus Evening (TIME) study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T18%3A00%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Home%20blood%20pressure%20monitors%20owned%20by%20participants%20in%20a%20large%20decentralised%20clinical%20trial%20in%20hypertension:%20the%20Treatment%20In%20Morning%20versus%20Evening%20(TIME)%20study&rft.jtitle=Journal%20of%20human%20hypertension&rft.au=Anbarasan,%20Thineskrishna&rft.date=2022-01-01&rft.volume=36&rft.issue=1&rft.spage=32&rft.epage=39&rft.pages=32-39&rft.issn=0950-9240&rft.eissn=1476-5527&rft_id=info:doi/10.1038/s41371-021-00496-6&rft_dat=%3Cproquest_pubme%3E2490125398%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2620903776&rft_id=info:pmid/33589759&rfr_iscdi=true |